PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för lobaplatin. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

38 hits

Bibliografisk träff 2023-01-24

Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer.

Wang M, Ma Z, Li Q, Yang W, Chen X, Geng Y, Luo D, Hu Y, Wu B, Jiang W, Su S, Ouyang W, Lu B.

Anticancer Drugs · clinical trial, phase ii; research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.1097/cad.0000000000001501

Bibliografisk träff 2023-01-19

Retracted: Nursing Observation on the Clinical Efficacy and Toxicity of Lobaplatin Compared with Cisplatin in the Treatment of Locally Advanced Hypopharyngeal Carcinoma Based on Intelligent CT Imaging.

Healthcare Engineering JO.

J Healthc Eng · retraction of publication; retraction notice · DOI 10.1155/2023/9846052

Bibliografisk träff 2023-01-18

Lobaplatin-based prophylactic hyperthermic intraperitoneal chemotherapy for T4 gastric cancer patients: A retrospective clinical study.

Zhong Y, Kang W, Hu H, Li W, Zhang J, Tian Y.

Front Oncol · research-article; journal article · DOI 10.3389/fonc.2023.995618

Bibliografisk träff 2023-01-01

Efficacy and Safety of Lobaplatin-TACE in the Treatment of Primary Hepatocellular Carcinoma: A Retrospective Study.

Lu H, Zheng C, Liang B, Xiong B.

Anticancer Agents Med Chem · research-article; journal article · DOI 10.2174/1871520622666220601115458

Bibliografisk träff 2022-12-01

Efficacy and toxicity of three concurrent chemoradiotherapy regimens in treating nasopharyngeal carcinoma: Comparison among cisplatin, nedaplatin, and lobaplatin.

Liang X, Liu Q, Yao W, Yang S.

Medicine (Baltimore) · research-article; journal article · DOI 10.1097/md.0000000000031187

Bibliografisk träff 2022-10-24

A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer.

Yan M, Yuan P, Ouyang Q, Cheng Y, Han G, Wang D, Ran L, Sun T, Zhao D, Bai Y, Yang S, Wang X, Wu R, Zeng X, Yao H, Ji X, Jiang J, Hu X, Lin H, Zheng L, Zhu Z, Ge W, Yang J, Cui T, Zhang X, Lu F, Li W, Xu H, Kang M, Gong P, Zou L, Liu J, Zhang H, Yu H, Xu B.

Ther Adv Med Oncol · research-article; journal article · DOI 10.1177/17588359221122715

Bibliografisk träff 2022-10-01

Thoracic perfusion of lobaplatin combined with endostar for treating malignant pleural effusions: A meta-analysis and systematic review.

Wang CQ, Liu FY, Wang W.

Medicine (Baltimore) · meta-analysis; research-article; systematic review; journal article · DOI 10.1097/md.0000000000030749

Bibliografisk träff 2022-09-15

CT-guided percutaneous chemical ablation combined with radiofrequency ablation for hepatocellular carcinomas in high-risk locations: lobaplatin vs. ethanol.

Li WD, Ding XY, Sun W, Guo XD, Sun SS, Shen YJ, Li L, Li W, Chen JL.

Am J Transl Res · research-article; journal article

Bibliografisk träff 2022-09-01

Efficacy of transcatheter arterial chemoembolization using pirarubicin-loaded microspheres combined with lobaplatin for primary liver cancer.

Zhang C, Dai YH, Lian SF, Liu L, Zhao T, Wen JY.

World J Clin Cases · research-article; journal article · DOI 10.12998/wjcc.v10.i27.9650

Bibliografisk träff 2022-08-28

Two non-small cell lung cancer (NSCLC) patients with brain metastasis harboring epidermal growth factor receptor (EGFR) G719X and L861Q mutations benefited from aumolertinib: two cases report and review of the literature.

Li L.

Heliyon · journal article; case reports; case-report · DOI 10.1016/j.heliyon.2022.e10407

Bibliografisk träff 2022-06-26

Albumin Paclitaxel Combined with Intrapleural Infusion of Bevacizumab + Lobaplatin for the Second-Line Treatment of Patients with Non-Squamous Non-Small Cell Lung Cancer.

Hou J, Mi X, Liu N, Yang Y, Qi Z, Li X, Lu X, Jiang X, Yu Y, Zhou Y, Ni Z, Fang Y, Jin N.

J Oncol · research-article; journal article · DOI 10.1155/2022/5901450

Bibliografisk träff 2022-06-24

Lobaplatin-based neoadjuvant chemotherapy for triple-negative breast cancer: a 5-year follow-up of a randomized, open-label, phase II trial.

Yan W, Wu X, Wang S, He C, Zhong L, Tang P, Ren L, Zhang T, Qi X, Zhang Y.

Ther Adv Med Oncol · research-article; journal article · DOI 10.1177/17588359221107111

Bibliografisk träff 2022-06-10

Albumin Paclitaxel Compared with 5-Penfluorouracil, Lobaplatin, and Albumin Paclitaxel Combined with 5-Penfluorouracil in the Treatment of Human Gastric Cancer Cell AGS Line Autophagy and Apoptosis.

Cheng X, Yang F, Wang Y, Nie W, Mahendra Upadhyay A, Zhang M, Wang Q, Yan Z.

Can J Gastroenterol Hepatol · research-article; journal article · DOI 10.1155/2022/6015877

Bibliografisk träff 2022-06-01

Chemotherapy-Induced Myelosuppression in Esophageal Cancer Patients: Risks and Suggestions for Its Management.

Zhang QL, Wu TT, Han Y, Zheng ZM, Zhang Y.

Curr Med Sci · journal article · DOI 10.1007/s11596-022-2587-3

Bibliografisk träff 2022-05-16

Analysis of clinical efficacy of intraperitoneal chemotherapy with lobaplatin for colorectal cancer.

Wang T, Yu X, Wang H, Zheng Y, Fei J, Wang X.

Minerva Surg · journal article · DOI 10.23736/s2724-5691.22.09583-1

Bibliografisk träff 2022-05-01

The efficacy of Endostar combined with platinum pleural infusion for malignant pleural effusion in tumor patients is significantly better than that of monotherapy, but the economy is lower: a systematic review, network meta-analysis and cost-effectiveness analysis.

Xia Y, Fang P, Zhang X, Su G, Shen A.

Ann Transl Med · research-article; journal article · DOI 10.21037/atm-22-2091

Bibliografisk träff 2022-02-14

Lobaplatin hyperthermic intraperitoneal chemotherapy plus cytoreduction and rechallenge using cetuximab for wild-type RAS peritoneal metastatic colon cancer: a case report and literature review.

Dai P, Ye Z, Cai Z, Luo Z, Qiu E, Lin Y, Cai J, Wang H, Li Z, Han S.

BMC Gastroenterol · review; journal article; case reports; case-report · DOI 10.1186/s12876-022-02109-z

Bibliografisk träff 2022-02-01

The anti-tumor effects of the combination of microwave hyperthermia and lobaplatin against breast cancer cells in vitro and in vivo.

Li X, Zhang X, Khan IU, Guo NN, Wang B, Guo Y, Xiao B, Zhang Y, Chu Y, Chen J, Guo F.

Biosci Rep · research support, non-u.s. gov't; research-article; journal article · DOI 10.1042/bsr20190878

Bibliografisk träff 2022-02-01

Elemene-containing hyperthermic intraperitoneal chemotherapy combined with chemotherapy for elderly patients with peritoneal metastatic advanced gastric cancer.

Chen ZX, Li J, Liu WB, Zhang SR, Sun H.

World J Clin Cases · research-article; journal article · DOI 10.12998/wjcc.v10.i5.1498

Bibliografisk träff 2022-01-01

Lobaplatin Induces Pyroptosis in Cervical Cancer Cells via the Caspase-3/GSDME Pathway.

Chen J, Ge L, Shi X, Liu J, Ruan H, Heng D, Ye C.

Anticancer Agents Med Chem · research support, non-u.s. gov't; journal article · DOI 10.2174/1871520621666211018100532

Bibliografisk träff 2021-11-27

Effect of combined treatment with lobaplatin and osthole on inducing apoptosis and inhibiting proliferation in human breast cancer MDA-MB-231 cells.

Liu N, Tian H, Zhang G, Sun N, Wang S.

Med Oncol · journal article · DOI 10.1007/s12032-021-01609-4

Bibliografisk träff 2021-11-01

Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer.

Yan MH, Liu F, Qu BL, Cai BN, Yu W, Dai XK.

World J Gastrointest Oncol · clinical trial; research-article; journal article · DOI 10.4251/wjgo.v13.i11.1781

Bibliografisk träff 2021-10-21

Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab.

Wu Q, Zhu C, Zhang S, Zhou Y, Zhong Y.

Front Oncol · research-article; journal article · DOI 10.3389/fonc.2021.762366

Bibliografisk träff 2021-09-13

Multicentre Comparison of the Toxicity and Effectiveness of Lobaplatin-Based <i>Versus</i> Cisplatin-Based Adjuvant Chemotherapy in Oesophageal Carcinoma.

Zheng Y, Li Y, Liu X, Sun H, Liang G, Hu J, Li L, Xing W.

Front Oncol · research-article; journal article · DOI 10.3389/fonc.2021.668140

Bibliografisk träff 2021-07-01

A study of the efficacy and tolerability of capecitabine and lobaplatin in advanced HER-2 negative breast cancer patients.

Yuan Y, Zhang L, Zhang Z, Qian Y, Teng Y.

Ann Transl Med · research-article; journal article · DOI 10.21037/atm-21-2702

Retracted publication 2021-06-30

Nursing Observation on the Clinical Efficacy and Toxicity of Lobaplatin Compared with Cisplatin in the Treatment of Locally Advanced Hypopharyngeal Carcinoma Based on Intelligent CT Imaging.

Li Y, Yang G, Li M, Tong X.

J Healthc Eng · retracted publication; research support, non-u.s. gov't; research-article; journal article · DOI 10.1155/2021/9982888

Bibliografisk träff 2021-03-09

Protein and Signaling Pathway Responses to rhIL-6 Intervention Before Lobaplatin Treatment in Osteosarcoma Cells.

Wang H, Li B, Yan K, Wu Y, Wen Y, Liu Y, Fan P, Ma Q.

Front Oncol · research-article; journal article · DOI 10.3389/fonc.2021.602712

Bibliografisk träff 2021-01-21

Paclitaxel increases the sensitivity of lung cancer cells to lobaplatin via PI3K/Akt pathway.

Ma D, Li S, Cui Y, Li L, Liu H, Chen Y, Zhou X.

Oncol Lett · retraction of publication; retraction notice · DOI 10.3892/ol.2021.12480

Bibliografisk träff 2021-01-12

Lobaplatin Enhances Radioactive <sup>125</sup>I Seed-Induced Apoptosis and Anti-Proliferative Effect in Non-Small Cell Lung Cancer by Suppressing the AKT/mTOR Pathway.

Rong JH, Li D, Li YL.

Onco Targets Ther · research-article; journal article · DOI 10.2147/ott.s288012

Bibliografisk träff 2020-11-24

Lobaplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastasis from Appendiceal and Colorectal Cancer: Safety and Efficacy Profiles.

Pei W, Zhou S, Zhang J, Zhou H, Chen H, Bi J, Zheng Z, Liu Z, Jiang Z, Wang Z, Liu Q, Wang X, Liang J, Feng Q.

Cancer Manag Res · research-article; journal article · DOI 10.2147/cmar.s281434